Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
The threat actor known as PlushDaemon has been observed using a previously undocumented Go-based network backdoor codenamed EdgeStepper to facilitate adversary-in-the-middle (AitM) attacks.
The DNS0.EU non-profit public DNS service focused on European users announced its immediate shut down due to time and resource constraints. Based in France, the service was built as a resilient ...
I no longer rely on my router’s DNS service after I started using Unbound on my home network. After setting up split-horizon DNS for internal subnets at home, I used public DNS servers for the ...
What would happen if, in an instant, the internet as you know it simply stopped working? No websites, no streaming, no online banking—just a blank void where your digital world once thrived. This is ...